These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 20696878
21. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria. Strateva T, Petrova G, Mitov I. J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744 [Abstract] [Full Text] [Related]
28. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO, Omri A. Int J Pharm; 2009 May 21; 373(1-2):141-6. PubMed ID: 19429299 [Abstract] [Full Text] [Related]
30. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G, McKevitt M, Elborn JS, Tunney MM. J Cyst Fibros; 2012 May 21; 11(3):163-72. PubMed ID: 22138067 [Abstract] [Full Text] [Related]
31. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor. Furiga A, Lajoie B, El Hage S, Baziard G, Roques C. Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774 [Abstract] [Full Text] [Related]
34. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Field TR, White A, Elborn JS, Tunney MM. Eur J Clin Microbiol Infect Dis; 2005 Oct 28; 24(10):677-87. PubMed ID: 16249934 [Abstract] [Full Text] [Related]
35. Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium. Diaz Iglesias Y, Van Bambeke F. Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015047 [Abstract] [Full Text] [Related]
36. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Nagant C, Tré-Hardy M, El-Ouaaliti M, Savage P, Devleeschouwer M, Dehaye JP. Appl Microbiol Biotechnol; 2010 Sep 24; 88(1):251-63. PubMed ID: 20625718 [Abstract] [Full Text] [Related]
38. Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Pseudomonas aeruginosa tobramycin-enhanced biofilm formation. Tahrioui A, Duchesne R, Bouffartigues E, Rodrigues S, Maillot O, Tortuel D, Hardouin J, Taupin L, Groleau MC, Dufour A, Déziel E, Brenner-Weiss G, Feuilloley M, Orange N, Lesouhaitier O, Cornelis P, Chevalier S. NPJ Biofilms Microbiomes; 2019 Sep 24; 5(1):15. PubMed ID: 31149345 [Abstract] [Full Text] [Related]
39. The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa. Mahdiun F, Mansouri S, Khazaeli P, Mirzaei R. Microb Pathog; 2017 Jun 24; 107():129-135. PubMed ID: 28323149 [Abstract] [Full Text] [Related]